Greengard J S, Heeb M J, Ersdal E, Walsh P N, Griffin J H
Biochemistry. 1986 Jul 1;25(13):3884-90. doi: 10.1021/bi00361a022.
The binding of human coagulation factor XI to washed human platelets was studied in the presence of zinc ions, calcium ions, and high molecular weight kininogen. Significant factor XI binding occurred at physiological levels of these metal ions when high molecular weight kininogen was present. Binding required platelet stimulation and was specific, reversible, and saturable. Scatchard analysis of the binding yielded approximately 1500 binding sites per platelet with an apparent dissociation constant of approximately 10 nM. Since the concentration of factor XI in plasma is about 25 nM, this suggests that in plasma factor XI binding sites on stimulated platelets might be saturated. Calcium ions and high molecular weight kininogen acted synergistically to enhance the ability of low concentrations of zinc ions to promote factor XI binding. The similarity between the concentrations of metal ions optimal for factor XI binding and those optimal for high molecular weight kininogen binding, as well as the ability of high molecular weight kininogen to modulate these metal ion effects, implies that factor XI and high molecular weight kininogen may form a complex on the platelet surface as they do in solution and on artificial negatively charged surfaces.
在锌离子、钙离子和高分子量激肽原存在的情况下,研究了人凝血因子XI与洗涤后的人血小板的结合。当存在高分子量激肽原时,在这些金属离子的生理水平下会发生显著的因子XI结合。结合需要血小板刺激,并且具有特异性、可逆性和饱和性。对结合进行Scatchard分析得出,每个血小板约有1500个结合位点,表观解离常数约为10 nM。由于血浆中因子XI的浓度约为25 nM,这表明在血浆中,受刺激血小板上的因子XI结合位点可能会饱和。钙离子和高分子量激肽原协同作用,增强低浓度锌离子促进因子XI结合的能力。因子XI结合的最佳金属离子浓度与高分子量激肽原结合的最佳金属离子浓度之间的相似性,以及高分子量激肽原调节这些金属离子效应的能力,意味着因子XI和高分子量激肽原可能像在溶液中和人工带负电表面上一样,在血小板表面形成复合物。